95 related articles for article (PubMed ID: 34256525)
1. Volatile oil of
Guesmi F; Prasad S; Tahri W; Dridi I; Ali MB; Hedfi A; Ismail IA; Landoulsi A
Front Biosci (Schol Ed); 2021 Jun; 13(1):1-13. PubMed ID: 34256525
[TBL] [Abstract][Full Text] [Related]
2.
Guesmi F; Prasad S; Ali MB; Ismail IA; Landoulsi A
Aging (Albany NY); 2021 Sep; 13(18):21975-21990. PubMed ID: 34543231
[TBL] [Abstract][Full Text] [Related]
3. Antinflammatory and anticancer effects of terpenes from oily fractions of Teucruim alopecurus, blocker of IκBα kinase, through downregulation of NF-κB activation, potentiation of apoptosis and suppression of NF-κB-regulated gene expression.
Guesmi F; Prasad S; Tyagi AK; Landoulsi A
Biomed Pharmacother; 2017 Nov; 95():1876-1885. PubMed ID: 28968948
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside compound K sensitizes human colon cancer cells to TRAIL-induced apoptosis via autophagy-dependent and -independent DR5 upregulation.
Chen L; Meng Y; Sun Q; Zhang Z; Guo X; Sheng X; Tai G; Cheng H; Zhou Y
Cell Death Dis; 2016 Aug; 7(8):e2334. PubMed ID: 27512955
[TBL] [Abstract][Full Text] [Related]
5. Ilimaquinone induces death receptor expression and sensitizes human colon cancer cells to TRAIL-induced apoptosis through activation of ROS-ERK/p38 MAPK-CHOP signaling pathways.
Do MT; Na M; Kim HG; Khanal T; Choi JH; Jin SW; Oh SH; Hwang IH; Chung YC; Kim HS; Jeong TC; Jeong HG
Food Chem Toxicol; 2014 Sep; 71():51-9. PubMed ID: 24930757
[TBL] [Abstract][Full Text] [Related]
6. Terpenes from essential oils and hydrolate of
Guesmi F; Tyagi AK; Prasad S; Landoulsi A
Oncotarget; 2018 Aug; 9(64):32305-32320. PubMed ID: 30190788
[TBL] [Abstract][Full Text] [Related]
7. Gamma-tocotrienol promotes TRAIL-induced apoptosis through reactive oxygen species/extracellular signal-regulated kinase/p53-mediated upregulation of death receptors.
Kannappan R; Ravindran J; Prasad S; Sung B; Yadav VR; Reuter S; Chaturvedi MM; Aggarwal BB
Mol Cancer Ther; 2010 Aug; 9(8):2196-207. PubMed ID: 20682650
[TBL] [Abstract][Full Text] [Related]
8. Icariin sensitizes human colon cancer cells to TRAIL‑induced apoptosis via ERK‑mediated upregulation of death receptors.
Kim B; Seo JH; Lee KY; Park B
Int J Oncol; 2020 Mar; 56(3):821-834. PubMed ID: 32124960
[TBL] [Abstract][Full Text] [Related]
9. Cardamonin sensitizes tumour cells to TRAIL through ROS- and CHOP-mediated up-regulation of death receptors and down-regulation of survival proteins.
Yadav VR; Prasad S; Aggarwal BB
Br J Pharmacol; 2012 Feb; 165(3):741-53. PubMed ID: 21797841
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of euchromatin histone-lysine N-methyltransferase 2 sensitizes breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through reactive oxygen species-mediated activating transcription factor 4-C/EBP homologous protein-death receptor 5 pathway activation.
Kim SY; Hong M; Heo SH; Park S; Kwon TK; Sung YH; Oh Y; Lee S; Yi GS; Kim I
Mol Carcinog; 2018 Nov; 57(11):1492-1506. PubMed ID: 29964331
[TBL] [Abstract][Full Text] [Related]
11. Tunicamycin enhances human colon cancer cells to TRAIL-induced apoptosis by JNK-CHOP-mediated DR5 upregulation and the inhibition of the EGFR pathway.
Guo X; Meng Y; Sheng X; Guan Y; Zhang F; Han Z; Kang Y; Tai G; Zhou Y; Cheng H
Anticancer Drugs; 2017 Jan; 28(1):66-74. PubMed ID: 27603596
[TBL] [Abstract][Full Text] [Related]
12. Bakuchiol sensitizes cancer cells to TRAIL through ROS- and JNK-mediated upregulation of death receptors and downregulation of survival proteins.
Park MH; Kim JH; Chung YH; Lee SH
Biochem Biophys Res Commun; 2016 Apr; 473(2):586-92. PubMed ID: 27033605
[TBL] [Abstract][Full Text] [Related]
13. Kaempferol Sensitizes Human Ovarian Cancer Cells-OVCAR-3 and SKOV-3 to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Induced Apoptosis via JNK/ERK-CHOP Pathway and Up-Regulation of Death Receptors 4 and 5.
Zhao Y; Tian B; Wang Y; Ding H
Med Sci Monit; 2017 Oct; 23():5096-5105. PubMed ID: 29070784
[TBL] [Abstract][Full Text] [Related]
14. An anthraquinone derivative, emodin sensitizes hepatocellular carcinoma cells to TRAIL induced apoptosis through the induction of death receptors and downregulation of cell survival proteins.
Subramaniam A; Loo SY; Rajendran P; Manu KA; Perumal E; Li F; Shanmugam MK; Siveen KS; Park JI; Ahn KS; Hui KM; Kumar AP; Sethi G
Apoptosis; 2013 Oct; 18(10):1175-87. PubMed ID: 23700228
[TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin-loaded nanoemulsion containing
Al-Otaibi WA; AlMotwaa SM
Drug Deliv; 2022 Dec; 29(1):2190-2205. PubMed ID: 35815706
[TBL] [Abstract][Full Text] [Related]
16. Gefitinib enhances human colon cancer cells to TRAIL-induced apoptosis of via autophagy- and JNK-mediated death receptors upregulation.
Chen L; Meng Y; Guo X; Sheng X; Tai G; Zhang F; Cheng H; Zhou Y
Apoptosis; 2016 Nov; 21(11):1291-1301. PubMed ID: 27629794
[TBL] [Abstract][Full Text] [Related]
17. 2-methoxy-5-amino-N-hydroxybenzamide sensitizes colon cancer cells to TRAIL-induced apoptosis by regulating death receptor 5 and survivin expression.
Stolfi C; Caruso R; Franzè E; Rizzo A; Rotondi A; Monteleone I; Fantini MC; Pallone F; Monteleone G
Mol Cancer Ther; 2011 Oct; 10(10):1969-81. PubMed ID: 21817114
[TBL] [Abstract][Full Text] [Related]
18. Enhanced tumor killing by Apo2L/TRAIL and CPT-11 co-treatment is associated with p21 cleavage and differential regulation of Apo2L/TRAIL ligand and its receptors.
Xiang H; Fox JA; Totpal K; Aikawa M; Dupree K; Sinicropi D; Lowe J; Escandón E
Oncogene; 2002 May; 21(22):3611-9. PubMed ID: 12032863
[TBL] [Abstract][Full Text] [Related]
19. Verrucarin A sensitizes TRAIL-induced apoptosis via the upregulation of DR5 in an eIF2α/CHOP-dependent manner.
Moon DO; Asami Y; Long H; Jang JH; Bae EY; Kim BY; Choi YH; Kang CH; Ahn JS; Kim GY
Toxicol In Vitro; 2013 Feb; 27(1):257-63. PubMed ID: 22982206
[TBL] [Abstract][Full Text] [Related]
20. 15-deoxy-Delta12,14-prostaglandin J2 up-regulates death receptor 5 gene expression in HCT116 cells: involvement of reactive oxygen species and C/EBP homologous transcription factor gene transcription.
Su RY; Chi KH; Huang DY; Tai MH; Lin WW
Mol Cancer Ther; 2008 Oct; 7(10):3429-40. PubMed ID: 18852146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
